e-learning
resources
Virtual 2020
Pre-Congress Content
Tuberculosis and adverse events in different populations
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Psychiatric Complications in Patients Receiving Treatment for Multi-Drug Resistant Tuberculosis
P. Chatterjee (Gurgaon (Haryana), India), S. Kotalwar (New Delhi, India), V. Goyal (Gurgaon, India), K. Sharma (Gurgaon, India)
Source:
Virtual Congress 2020 – Tuberculosis and adverse events in different populations
Session:
Tuberculosis and adverse events in different populations
Session type:
E-poster session
Number:
501
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Chatterjee (Gurgaon (Haryana), India), S. Kotalwar (New Delhi, India), V. Goyal (Gurgaon, India), K. Sharma (Gurgaon, India). Psychiatric Complications in Patients Receiving Treatment for Multi-Drug Resistant Tuberculosis. 501
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
PES Pathogens in Elderly Patients with Acquired Pneumonia in the Community
Source: Virtual Congress 2020 – Clinical challenges in pneumonia
Year: 2020
Treatment With Baricitinib for Patients With COVID-19 Infections: A Case-Series Study
Source: Virtual Congress 2021 – Diagnosis and management of COVID-19
Year: 2021
Early Fever Associated with Clinical Outcomes in Patients with Coronavirus Disease 2019
Source: Virtual Congress 2021 – COVID - 19: lessons learned
Year: 2021
Clinical Features Associated with Linezolid Resistance Among Multidrug Resistant Tuberculosis Patients at a Tertiary Care Hospital in Mumbai, India
Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis
Year: 2020
Use of the Recombinant Tuberculosis Allergen in the Early Diagnosis of Tuberculosis in Paediatric Patients
Source: International Congress 2018 – Groups who are susceptible to tuberculosis: children, pregnant women and elderly people
Year: 2018
Factors Affecting Weaning Failure in Critical Patients with Urgent Gastrointestinal Surgery
Source: International Congress 2019 – COPD and other specific entities in intensive care unit medicine
Year: 2019
Late Breaking Abstract - Characteristics of Patients Diagnosed with Severe Asthma at UK Specialist Centres: Variation by Ethnicity
Source: International Congress 2019 – Bronchiectasis
Year: 2019
Community-Acquired Pneumococcal Pneumonia in Virologically Suppressed HIV-Infected Adult Patients: A Matched Case-Control Study
Source: International Congress 2017 – Respiratory infections in critically ill and immuno-depressed patientes
Year: 2017
Prevalence and Characteristics of Patients Receiving Antifibrotic Therapy for Idiopathic Pulmonary Fibrosis
Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries
Year: 2020
Thirty-Day Readmission Among Patients With Non-Ventilator Hospital Acquired Pneumonia and Effects on Outcomes.
Source: International Congress 2019 – Severe pneumonia: epidemiology, mechanisms and treatment
Year: 2019
Does the Outpatient Pulmonary Rehabilitation Program Affect Mortality in Patients with COPD?
Source: Virtual Congress 2020 – Personalised treatment of obstructive diseases
Year: 2020
Does a Tailored Intervention to Promote Adherence in Patients with Chronic Lung Disease Affect Exacerbations?
Source: International Congress 2019 – Exacerbations of airway diseases
Year: 2019
Time to Blood Culture Positivity as a Predictor of Clinical Outcomes and Severity in Adults with Bacteremic Pneumococcal Pneumonia
Source: International Congress 2017 – Update on community acquired pneumonia
Year: 2017
Risk Factors for Mortality in Patients with Idiopathic Pulmonary Fibrosis Followed at Intensive Care Unit due to Acute Respiratory Failure
Source: International Congress 2018 – What is new in idiopathic interstitial pneumonias?
Year: 2018
Modes of Disease Progression in Different Forms of Interstitial Lung Disease with Usual Interstitial Pneumonia Histology in Patients with Idiopathic and Non-idiopathic Etiologies - A Single Center Experience
Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside
Year: 2019
Higher Age Puts Lung-Cancer Patients at Risk for Not Receiving Anti-cancer Treatment
Source: International Congress 2019 – Symptoms, risks, complications and palliative care in thoracic oncology
Year: 2019
Treatment Outcomes of Tuberculosis among New Smear Positive and Retreatment Cases: Retrospective Study in Two Egyptian Governorates
Source: International Congress 2019 – Tuberculosis epidemiology, bronchiectasis, other infections and spirometry
Year: 2019
O'Donnell Criteria as a Score of Bad Prognosis in Hospitalized Patients with Acute Exacerbation of Non-Cystic Fibrosis Bronchiectasis, an Observetional Study
Source: Virtual Congress 2021 – Bronchiectasis
Year: 2021
Nature, Magnitude and Risk Factors of Adverse Drug Reactions in Multidrug Resistant TB Patients in Eritrea
Source: International Congress 2018 – Drug-resistant tuberculosis and the sequelae of pulmonary tuberculosis
Year: 2018
Clinical Characteristics and Treatment Outcome of Multidrug-Resistant Tuberculosis (MDR-TB) in a Tertiary Centre in Malaysia: A Two-year Experience
Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept